Cargando…

OR19-3 Utility of the Levothyroxine Absorption Test: The Mayo Clinic Experience

Introduction: While hormone replacement with levothyroxine (LT4) is the most effective management for hypothyroidism, there is a subset of patients who remain hypothyroid despite high doses of LT4. These patients warrant evaluation for conditions that may contribute to poor LT4 absorption. Several c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gonzales, Kristen, Stan, Marius, Bernet, Victor, Castro, M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Endocrine Society 2019
Materias:	Thyroid
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6554972/ http://dx.doi.org/10.1210/js.2019-OR19-3

Ejemplares similares

SAT-483 Levothyroxine Absorption Test: A Potential Therapeutic Tool for Levothyroxine Malabsorption
por: Arora, Tanureet, et al.
Publicado: (2020)

SAT470 Outcomes Of Radiofrequency Ablation For Autonomously Functioning Thyroid Adenoma- Mayo Clinic Experience 
por: Dhanasekaran, Maheswaran, et al.
Publicado: (2023)

SAT-503 Levothyroxine Absorption Testing in Three Patients with Severe Hypothyroidism on Adequate Replacement
por: Martinez, Eduardo Andres Lopez, et al.
Publicado: (2020)

SAT-505 Non-Adherence to Levothyroxine Treatment, a Condition Not to Be Ignored nor Forgotten, Should Be Assessed by Thyroxine Absorption Test
por: Effraimidis, Grigorios, et al.
Publicado: (2020)

MON-623 Higher FT4 Results in Levothyroxine-Treated Patients with Normal TSH Compared to Patients without Thyroid Disease
por: Galior, Kornelia, et al.
Publicado: (2019)

Development of Intranasal Levothyroxine Powder Delivery for Hypothyroidism
por: Imran, Syed Ali, et al.
Publicado: (2021)

SUN-592 Goiters and Levothyroxine Do Not Always Mix
por: Steven, Scott, et al.
Publicado: (2019)

SAT-504 Delayed Hypersensitivity to Levothyroxine, and Oral Desensitization
por: Sandooja, Rashi, et al.
Publicado: (2020)

ODP491 Levothyroxine Withdrawal Presenting as Myxedema Madness
por: Trusty, Rhonda-Kaye, et al.
Publicado: (2022)

SAT-425 Characteristics of Hypothyroid Patients Achieving Long Term Euthyroidism on Levothyroxine Treatment
por: Tandeter, Howard, et al.
Publicado: (2020)

SAT-460 Myxedema Coma Mimicking Cardiogenic Shock Treated with Levothyroxine
por: Chaker, Bayan, et al.
Publicado: (2020)

Severe Rhabdomyolysis and Acute Renal Failure Due to Noncompliance to Levothyroxine Therapy
por: Raj, Rishi, et al.
Publicado: (2021)

A Tale of Two Therapies- A Comparison of Armour Thyroid and Levothyroxine
por: Shah, Meghna, et al.
Publicado: (2021)

ODP490 Levothyroxine Dosing Based on BMI and Different Causes of Hypothyroidism
por: Darquea, Andres, et al.
Publicado: (2022)

LBODP105 A Case of Significantly Increased Levothyroxine Requirement With Rifampin Therapy
por: Naher, Kamrun, et al.
Publicado: (2022)

Stopping Levothyroxine Therapy in Subclinical Hypothyroidism, Perhaps We Could Start a Trend
por: Albashaireh, Arwa, et al.
Publicado: (2021)

SAT-608 Severe Exogenous Hyperthyroidism Secondary to Intentional Overdose of Levothyroxine in a Patient with Bipolar Disorder
por: Thapa, Sudan, et al.
Publicado: (2019)

A Rare Case of a Toxic Thyroid Nodule Found in a Hypothyroid Patient on Levothyroxine Therapy
por: Purewal, Tiffany, et al.
Publicado: (2021)

RF23 | PSAT259 Comparable Bioavailability of a Novel Levothyroxine Solution when Administered with Coffee
por: Washington, Kris, et al.
Publicado: (2022)

SAT475 Levothyroxine and Liothyronine Treated Myxedema Coma with Irreversible Cardiopulmonary Failure: A Rare Phenomenon
por: Menon, Trisha, et al.
Publicado: (2023)

SAT-LB85 Use of Weekly Levothyroxine Regimen for Rapid Normalization of Thyroid Hormone Levels: A Case Report
por: Escudero, Jose Renato Martinez, et al.
Publicado: (2020)

SAT-443 Impact of Fasting on Plasma Thyrotropin in Hypothyroid Patients Taking Levothyroxine During Ramadan (IFT-R Study)
por: El-Kaissi, Samer, et al.
Publicado: (2020)

PSAT364 High-Dose Levothyroxine to Exclude Malabsorption as a Cause of Refractory Hypothyroidism in Hospitalized Patients: Two Cases
por: Majumdar, Sachin, et al.
Publicado: (2022)

ODP476 Does Levothyroxine Intake at Breakfast Matter for Patients With Hypothyroidism? A Meta- Analysis of Randomized Control Trials
por: Cheng, Ce, et al.
Publicado: (2022)

Physiologic Effects of Levothyroxine and Liothyronine in the in Older Individuals With Persistent Subclinical Hypothyroidism: A Randomized, Double-Blind, Cross-Over Study
por: Meizlik, Paige, et al.
Publicado: (2021)

ODP517 Successful Treatment of Myxedema Coma after SARS-CoV-2 infection with Combination Oral Levothyroxine and Liothyronine
por: Dimayuga, Diana Colleen, et al.
Publicado: (2022)

A Rare Case of Massive Pericardial Effusion as the First Presentation of Hashimoto’s Hypothyroidism With Complete Resolution With Levothyroxine Treatment - A Case Report
por: Abdelmasih, Randa, et al.
Publicado: (2021)

ODP598 Liquid levothyroxine (L-T4) maintains more stable TSH levels in hypothyroid patients, than tablet L-T4
por: Antonelli, Alessandro, et al.
Publicado: (2022)

LBSAT247 Factors Guiding Successful Treatment Discontinuation In Levothyroxine Replacement Therapy Overuse: Short And Long-term Observation Data Of 802 Subjects.
por: Livadas, Sarantis, et al.
Publicado: (2022)

RF23 | PSAT365 An Open-Label Therapeutic Efficacy Study of Tirosint (Levothyroxine Sodium) Capsules in Thyroidectomized Patients Taking Proton Pump Inhibitors
por: Sachmechi, Issac, et al.
Publicado: (2022)

THU664 Discontinuation Of Low-dose Levothyroxine Therapy For Patients With Subclinical Hypothyroidism Is Feasible: A Pilot, Randomized, Double-blind, Placebo-controlled Trial
por: Maraka, Spyridoula, et al.
Publicado: (2023)

MON-570 Clinical Utility of ThyroSeq v3 Genomic Classifier Test in Detecting Gene Fusions in Thyroid Nodules
por: Nikiforova, Marina, et al.
Publicado: (2019)

PSAT245 Feasibility of introducing a conversation aid for patients with thyroid nodules in clinical practice: Understanding the clinician experience
por: Chavez, Chandani Patel, et al.
Publicado: (2022)

RF23 | PSAT258 Comparable Bioavailability of a Novel Levothyroxine Solution taken 10 or 30 minutes prior to a High-Fat, High-Calorie Breakfast
por: Washington, Kris, et al.
Publicado: (2022)

Transdermal Absorption of Methimazole- a Cat’s Tale
por: Mittal, Ashima, et al.
Publicado: (2021)

No Effect of Levothyroxine and Levothyroxine-Induced Subclinical Thyrotoxicosis on the Pharmacokinetics of Sorafenib in Healthy Male Subjects
por: Huang, Funan, et al.
Publicado: (2017)

PSAT246 Decision Making for Patients with Thyroid Nodules: Understanding the Patient's Experience
por: Patel Chavez, Chandani, et al.
Publicado: (2022)

MON-498 Thyroseq V3 GC for Bethesda III and IV: An Institutional Experience
por: Desai, Dimpi, et al.
Publicado: (2020)

SAT-424 Assessing Content Validity of the Graves’ Ophthalmopathy Quality of Life Questionnaire (GO-QOL) in the United States
por: Stan, Marius N, et al.
Publicado: (2020)

Adequate timing and constant supervision are the keys for successful implementation of levothyroxine or levothyroxine/paracetamol absorption test
por: Lewandowski, Krzysztof C., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_nvl7rpoe216jfdrr9irr93q48u